Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 1, 2024
Uveal
melanoma
(UM)
is
the
most
common
primary
intraocular
tumour
in
adults.
Local
resection,
radiation
therapy,
and
enucleation
are
current
first-line,
UM
treatments.
However,
regardless
of
treatment
received,
around
50%
patients
will
develop
metastatic
disease
within
five
to
7
years.
In
largest
published
series
unselected
with
(mUM),
median
survival
time
after
diagnosis
metastasis
was
3.6
months,
less
than
1%
surviving
beyond
5
Approved
drugs
for
mUM
include
systemic
tebentafusp-tebn
or
isolated
hepatic
perfusion
(IHP)
melphalan.
these
only
available
a
subset
improve
by
few
highlighting
urgent
need
new
Accurately
predicting
which
at
high
risk
metastases
also
crucial.
Researchers
developing
gene
expression
signatures
create
reliable
prognostic
models
aimed
improving
patient
follow-up
strategies.
this
review
we
discuss
evidence
supporting
ferroptosis,
non-apoptotic
form
cell
death,
as
potential
novel
target
prognosticator
UM.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 13, 2025
Gene
therapy
has
long
been
a
cornerstone
in
the
treatment
of
rare
diseases
and
genetic
disorders,
offering
targeted
solutions
to
conditions
once
considered
untreatable.
As
field
advances,
its
transformative
potential
is
now
expanding
into
oncology,
where
personalized
therapies
address
immune-related
complexities
cancer.
This
review
highlights
innovative
therapeutic
strategies,
including
gene
replacement,
silencing,
oncolytic
virotherapy,
CAR-T
cell
therapy,
CRISPR-Cas9
editing,
with
focus
on
their
application
both
hematologic
malignancies
solid
tumors.
CRISPR-Cas9,
revolutionary
tool
precision
medicine,
enables
precise
editing
cancer-driving
mutations,
enhancing
immune
responses
disrupting
tumor
growth
mechanisms.
Additionally,
emerging
approaches
target
ferroptosis—a
regulated,
iron-dependent
form
death—offering
new
possibilities
for
selectively
inducing
death
resistant
cancers.
Despite
significant
breakthroughs,
challenges
such
as
heterogeneity,
evasion,
immunosuppressive
microenvironment
(TME)
remain.
To
overcome
these
barriers,
novel
like
dual-targeting,
armored
cells,
combination
checkpoint
inhibitors
ferroptosis
inducers
are
being
explored.
rise
allogeneic
“off-the-shelf”
offers
scalable
more
accessible
options.
The
regulatory
landscape
evolving
accommodate
advancements,
frameworks
RMAT
(Regenerative
Medicine
Advanced
Therapy)
U.S.
ATMP
(Advanced
Therapy
Medicinal
Products)
Europe
fast-tracking
approval
therapies.
However,
ethical
considerations
surrounding
CRISPR-based
editing—such
off-target
effects,
germline
ensuring
equitable
access—remain
at
forefront,
requiring
ongoing
oversight.
Advances
non-viral
delivery
systems,
lipid
nanoparticles
(LNPs)
exosomes,
improving
safety
efficacy
By
integrating
innovations
addressing
concerns,
poised
revolutionize
cancer
treatment,
providing
durable,
effective,
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 9549 - 9574
Published: Sept. 1, 2024
Molecular
imaging
is
an
advanced
technology
that
utilizes
specific
probes
or
markers
in
conjunction
with
cutting-edge
techniques
to
observe
and
analyze
the
localization,
distribution,
activity,
interactions
of
biomolecules
within
living
organisms.
Tumor
molecular
imaging,
by
enabling
visualization
quantification
characteristics
tumor
cells,
facilitates
a
deeper
more
comprehensive
understanding
tumors,
providing
valuable
insights
for
early
diagnosis,
treatment
monitoring,
cancer
biology
research.
However,
image
quality
still
requires
improvement,
nanotechnology
has
significantly
propelled
advancement
imaging.
Currently,
nanoparticle-based
technologies
encompass
radionuclide
fluorescence
magnetic
resonance
ultrasound
photoacoustic
multimodal
among
others.
As
our
microenvironment
deepens,
design
nanoparticle
also
evolved,
offering
new
perspectives
expanding
applications
Beyond
diagnostics,
there
marked
trend
towards
integrated
diagnosis
therapy,
image-guided
playing
pivotal
role.
This
includes
surgery,
photodynamic
chemodynamic
therapy.
Despite
continuous
advancements
innovative
developments
many
these
remain
experimental
stage
require
breakthroughs
before
they
can
be
fully
into
clinical
practice.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 23, 2025
Ferroptosis
is
a
novel
form
of
cell
death
distinct
from
traditional
mechanisms,
characterized
by
the
accumulation
iron
ions
and
production
lipid
peroxides.
It
not
only
affects
survival
tumor
cells
but
also
closely
linked
to
changes
in
microenvironment.
Lung
cancer
one
leading
malignancies
worldwide
terms
incidence
mortality,
its
complex
biological
mechanisms
resistance
make
treatment
challenging.
Recent
studies
have
shown
that
ferroptosis
plays
key
role
onset
progression
lung
cancer,
with
intricate
regulatory
influencing
development
response
therapy.
As
research
into
deepens,
related
molecular
pathways,
such
as
glutamate
metabolism,
antioxidant
defense,
been
gradually
revealed.
However,
clinical
practice,
ferroptosis-based
therapeutic
strategies
for
are
still
their
early
stages.
Challenges
remain,
including
incomplete
understanding
specific
ferroptosis,
insufficient
on
factors,
limited
insight
interactions
within
Therefore,
effective
modulation
enhance
remains
an
urgent
issue.
This
review
summarizes
analyzes
factors
interaction
microenvironment,
further
explores
potential
targeting
ferroptosis.
By
synthesizing
latest
research,
this
paper
aims
provide
new
perspectives
directions
treatment,
goal
advancing
applications.
MedComm,
Journal Year:
2025,
Volume and Issue:
6(3)
Published: Feb. 23, 2025
Ferroptosis
is
a
distinct
form
of
iron-dependent
programmed
cell
death
characterized
primarily
by
intracellular
iron
accumulation
and
lipid
peroxidation.
Multiple
cellular
processes,
including
amino
acid
metabolism,
various
signaling
pathways,
autophagy,
have
been
demonstrated
to
influence
the
induction
progression
ferroptosis.
Recent
investigations
elucidated
that
ferroptosis
plays
crucial
role
in
pathogenesis
pulmonary
disorders,
lung
injury,
chronic
obstructive
disease,
fibrosis,
asthma.
increasingly
recognized
as
promising
novel
strategy
for
cancer
treatment.
Various
immune
cells
within
tumor
microenvironment,
CD8+
T
cells,
macrophages,
regulatory
natural
killer
dendritic
shown
induce
modulate
process
through
regulation
metabolism
pathways.
Conversely,
can
reciprocally
alter
metabolic
environment,
leading
activation
or
inhibition
functions,
thereby
modulating
responses.
This
paper
reviews
molecular
mechanism
describes
discusses
connection
between
microenvironment
diseases,
development
prospect
their
interaction
treatment
diseases.
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 21, 2025
Abstract
Caspase-independent
cell
death
(CICD)
has
recently
become
a
very
important
mechanism
in
lung
cancer,
particular,
to
overcome
critical
failure
apoptotic
that
is
common
disease
progression
and
treatment
failures.
The
pathways
involved
CICD
span
from
necroptosis,
ferroptosis,
mitochondrial
dysfunction,
autophagy-mediated
death.
Its
potential
therapeutic
applications
have
been
highlighted.
Glutathione
peroxidase
4
(GPX4)
inhibition-driven
ferroptosis
drug
resistance
non-small
cancer
(NSCLC).
In
addition,
necroptosis
involving
RIPK1
RIPK3
causes
tumor
modulation
of
immune
responses
the
microenvironment
(TME).
Mitochondrial
are
for
through
metabolic
redox
homeostasis.
Ferroptosis
amplified
by
reactive
oxygen
species
(ROS)
lipid
peroxidation
cells,
depolarization
induces
oxidative
stress
leads
mitochondria-mediated
autophagy,
or
mitophagy,
results
clearance
damaged
organelles
under
conditions,
while
this
function
also
linked
when
dysregulated.
role
autophagy
regulated
ATG
proteins
PI3K/AKT/mTOR
pathway
dual:
suppress
sensitize
cells
therapy.
A
promising
approach
enhancing
outcomes
involves
targeting
mechanisms
CICD,
including
inducing
SLC7A11
inhibition,
modulating
ROS
generation,
combining
inhibition
with
chemotherapy.
Here,
we
review
molecular
underpinnings
particularly
on
their
transform
treatment.
Virulence,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 29, 2025
Epstein-Barr
Virus
(EBV),
Kaposi's
sarcoma-associated
herpesvirus
(KSHV),
and
human
T-cell
leukemia
virus
type
1
(HTLV-1)
are
key
infectious
agents
linked
to
the
development
of
various
hematological
malignancies,
including
Hodgkin's
lymphoma,
non-Hodgkin's
adult
leukemia/lymphoma.
This
review
highlights
critical
knowledge
gaps
in
understanding
role
ferroptosis,
a
novel
form
cell
death,
virus-related
tumors.
We
focus
on
how
ferroptosis
influences
host
response
these
viral
infections,
revealing
groundbreaking
mechanisms
by
which
three
viruses
differentially
regulate
core
pathways
such
as
iron
homeostasis,
lipid
peroxidation,
antioxidant
systems,
thereby
promoting
malignant
transformation
cells.
Additionally,
we
explore
potential
antiviral
drugs
modulators
treatment
virus-associated
malignancies.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 9, 2024
Lung
cancer
has
high
metastasis
and
drug
resistance.
The
prognosis
of
lung
patients
is
poor
the
patients’
survival
chances
are
easily
neglected.
Ferroptosis
a
programmed
cell
death
proposed
in
2012,
which
differs
from
apoptosis,
necrosis
autophagy.
novel
type
regulated
driven
by
iron-dependent
lipid
peroxidation
subsequent
plasma
membrane
ruptures.
It
broad
prospects
field
tumor
disease
treatment.
At
present,
multiple
studies
have
shown
that
biological
compounds
can
induce
ferroptosis
cells,
exhibits
significant
anti-cancer
effects,
they
advantages
safety,
minimal
side
less
possibility
to
In
this
review,
we
summarize
used
for
treatment
focusing
on
its
mechanism.
addition,
systematically
review
current
research
status
combining
nanotechnology
with
treatment,
shed
new
light
targeting
pathways
applying
compounds-based
therapies.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 6, 2024
Thyroid-associated
ophthalmopathy
(TAO)
is
an
inflammatory
orbital
disease
associated
with
autoimmune
thyroid
disorders.
Owing
to
the
ambiguous
nature
of
pathogenesis,
contemporary
pharmacological
treatment
strategies
predominantly
involve
use
glucocorticoids
and
immunosuppressants.
However,
adverse
effects
these
agents
in
clinical
practice
necessitate
further
investigation
into
disease's
pathogenesis
identification
novel
therapeutic
targets
interventions.
Recent
studies
suggest
that
ferroptosis,
a
form
regulated
cell
death,
may
play
role
TAO
pathogenesis.
This
review
aims
explore
involvement
ferroptosis
evaluate
its
potential
as
target.
Key
topics
include
epidemiology,
manifestations,
pathophysiology
TAO,
along
molecular
mechanisms
ferroptosis.
Evidence
supporting
implications
targeting
this
pathway
are
also
discussed,
alongside
challenges
future
directions
emerging
research
area.